Background: The increased use of medical therapies has led to increased medical costs. To provide insight into the value of this increased spending, we compared gains in life expectancy with the increased costs of care from 1960 through 2000. Methods: We estimated life expectancy in 1960, 1970, 1980, 1990, and 2000 for four age groups. To control for the influence of nonmedical factors on survival, we assumed in our base-case analysis that 50 percent of the gains were due to medical care. We compared the adjusted increases in life expectancy with the lifetime cost of medical care in the same years. Results: From 1960 through 2000, the life expectancy for newborns increased by 6.97 years, lifetime medical spending adjusted for inflation in...
The rate of increase of longevity has varied considerably across U.S. states since 1991. This paper ...
According to government figures, total health care spending in the U.S. in 1999 was $1.316 trillion....
We analyze the influence of technological progress on pharmaceuticals on rising health expenditures ...
BACKGROUND: The increased use of medical therapies has led to increased medical costs. To provide in...
It is widely known that medical costs have increased over time. In the United States, as in most of ...
Measuring the lifetime costs and benefits of medical technologies is essential in evaluating technol...
We estimate a stochastic life-cycle model of endogenous health spending, asset accumulation and reti...
Between 1960 and 1997, life expectancy at birth of Americans increased approximately 10 % from 69....
Is medical care worth it? Conventional wisdom says no, but my answer is emphatically yes. The benefi...
Basic research is a public good, for which social returns may greatly exceed private ones. This pape...
We evaluate the economic value of increases in life expectancy, improvements in health, and treatmen...
We study the impact of health insurance expansion on medical spending, longevity and welfare in an O...
In the United States, health care technology has contributed to rising survival rates, yet health ca...
We use data from the Medicare Current Beneficiary Survey (MCBS) to document the medical spending of ...
This paper examines the role of medical care in improving health and compares that value of better h...
The rate of increase of longevity has varied considerably across U.S. states since 1991. This paper ...
According to government figures, total health care spending in the U.S. in 1999 was $1.316 trillion....
We analyze the influence of technological progress on pharmaceuticals on rising health expenditures ...
BACKGROUND: The increased use of medical therapies has led to increased medical costs. To provide in...
It is widely known that medical costs have increased over time. In the United States, as in most of ...
Measuring the lifetime costs and benefits of medical technologies is essential in evaluating technol...
We estimate a stochastic life-cycle model of endogenous health spending, asset accumulation and reti...
Between 1960 and 1997, life expectancy at birth of Americans increased approximately 10 % from 69....
Is medical care worth it? Conventional wisdom says no, but my answer is emphatically yes. The benefi...
Basic research is a public good, for which social returns may greatly exceed private ones. This pape...
We evaluate the economic value of increases in life expectancy, improvements in health, and treatmen...
We study the impact of health insurance expansion on medical spending, longevity and welfare in an O...
In the United States, health care technology has contributed to rising survival rates, yet health ca...
We use data from the Medicare Current Beneficiary Survey (MCBS) to document the medical spending of ...
This paper examines the role of medical care in improving health and compares that value of better h...
The rate of increase of longevity has varied considerably across U.S. states since 1991. This paper ...
According to government figures, total health care spending in the U.S. in 1999 was $1.316 trillion....
We analyze the influence of technological progress on pharmaceuticals on rising health expenditures ...